Lumos Pharma(LUMO) - 2022 Q3 - Earnings Call Presentation

P H A R M A 1 Interim Analysis OraGrowtH210 & OraGrowtH212 November 14, 2022 Forward Looking Statements 2 This presentation contains proprietary and confidential information of Lumos Pharma, Inc. ("Lumos," "we," "us" and "our"), and such content should be considered "Confidential Information" and covered by your confidentiality obligations to Lumos. This presentation is made solely for informational purposes, and no representation or warranty, express or implied, is made by Lumos or any of its representativ ...